Effects of Imipramine, Fluvoxamine and Depressive Mood on Autonomic Cardiac Functioning in Major Depressive Disorder

Pharmacopsychiatry

Volumn 37, Issue 1, 2004, Pages 18-25

  Volkers, A C ^a   Tulen, J H M ^a   Van Den Broek, W W ^a   Bruyn, J A ^a   Passchier, J ^a   Pepplinkhuizen, L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; IMIPRAMINE;

ADULT; AGED; ARTICLE; ATYPICAL DEPRESSION; BLOOD PRESSURE REGULATION; CARDIOVASCULAR PERFORMANCE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HEART RATE VARIABILITY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PARASYMPATHETIC NERVE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; STANDING; SUPINE POSITION; SYMPATHETIC TONE;

ADULT; AFFECT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FLUVOXAMINE; HEART; HEART RATE; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; PERSONALITY INVENTORY; TREATMENT OUTCOME;

EID: 1242264022     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815470     Document Type: Article

References (35)

1. Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol 1985; 249: H867-875
2. Balogh S, Fitzpatrick DF, Hendricks SE, Paige SR. Increases in heart rate variability with successful treatment in patients with major depressive disorder, Psychopharmacol Bull 1993; 29(2): 201-206
3. Bock RD. Within-subject experimentation in psychiatric research. In Gibbons RD, Dyskens MW, editors. Statistical and methodological advances in psychiatric research New York: Spectrum Books, 1983: 59-90
4. Endicott J, Spitzer RL A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiat 1978; 35: 837-844
5. Gibbons RD, Hedeker D, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiat 1993; 50: 739-750
6. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296
7. Hewer W, Rost W, Gattaz WF. Cardiovascular effects of fluvoxamine and maprotiline in depressed patients. Eur Arch Psychiatry Clin Neurosci 1995; 246(1): 1-6
8. Laird LK, Lydiard RB, Morton WA, Steele TE, Kellner C, Thompson NM et al. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. J Clin Psychiat 1993; 54(6): 224-228
9. Lederbogen F, Gernoth C, Weber B, Colla M, Kniest A, Heuser I et al. Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability. J Clin Psychopharmacol 2001; 21(2): 238-239
10. Lehofer M, Moser M, Hoehn-Saric R, McLeod D, Liebmann P, Drnovsek B et al. Major depression and cardiac autonomic control. Biol Psychiat 1997; 42(10): 914-919
11. Littman AB. Review of psychosomatic aspects of cardiovascular disease. Psychother Psychosom 1993; 60(3-4): 148-167
12. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492
13. McLeod DR, Hoehn-Saric R, Porges SW, Zimmerli WD. Effects of alprazolam and imipramine on parasympathetic cardiac control in patients with generalized anxiety disorder. Psychopharmacology 1992; 107(4): 535-540
14. Moser M, Lehofer M, Hoehn-Saric R, McLeod DR, Hildebrandt G, Steinbrenner B et al. Increased heart rate in depressed subjects in spite of unchanged autonomic balance? J Affect Disord 1998; 48: 115-124
15. Mulder LJM, Van Dellen HJ, Van Der Meulen P, Opheikens B. CARSPAN: a spectral analysis program for cardiovascular time series. In Maarse FJ, Mulder LJM, Sjouw W, Akkerman A, editors. Computers in Psychology: Methods, Instrumentation and Psychodiagnostica Lisse, The Netherlands: Swets and Zeitlinger, 1988: 30-38
16. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiat 1998; 55(7): 580-592
17. Parati G, Casadei R, Gropelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989; 3: 647-655
18. Parati G, Di Rienzo M, Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 2000; 18: 7-19
19. Penaz J. Beitrag zur Fortlaufenden indirekten blutdruckmessung. Z Inn Med 1976; 31: 1030-1033
20. Rechlin T. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmacol 1994; 14(6): 392-395
21. Robbe HWJ, Mulder LJM, Ruddel H, Veldman JBP, Langewitz WA, Mulder G. Assessment of baroreflex sensitivity by means of spectral analysis. Hypertension 1987; 10: 538-543
22. Saul JP, Berger RD, Albrecht P, Stein SP, Chen MH, Cohen RJ. Transfer function analysis of the circulation: unique insights into cardiovascular regulation. Am J Physiol 1991; 261: H1231-1245
23. Shores MM, Pascualy M, Lewis NL, Flatness D, Veith RC. Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology 2001; 26(4): 433-439
24. Szabo B, Karsch V, Starke K. Effects of inhibitors of neuronal uptake of 5-HT on sympathetic cardiovascular regulation. J Cardiovasc Pharmacol 1992; 20(1): 99-107
25. Task Force, heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17: 354-381
26. Tulen JH, Bruijn JA, De Man KJ, Pepplinkhuizen L, Van Den Meiracker AH, Man in 't Veld AJ. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J Clin Psychopharmacol 1996; 16(2): 135-145
27. Van Dellen HJ, Aasman J, Mulder LJM, Mulder G. Time domain versus frequency domain measures of heart rate variability. In: Orlebeke J, Mulder G, Van Doornen L, editors. Psychophysiology of autonomic control New York: Plenum Press, 1985: 353-374
28. Van Steenis HG, Tulen JHM, Mulder LJM. Heart rate variability spectra based on non-equidistant sampling: the spectrum of counts and the instantaneous heart rate frequency. Med Eng Phys 1994; 16: 355-362
29. Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiat 1994; 51(5): 411-422
30. Verbeke S, Molenberghs S. Linear mixed models in practise; a SAS-oriented approach. In Springer DB, editor. Multiple imputation for non-response in surveys New York: Weley, 1987
31. Volkers AC, TulenJHM, Van de Broek WW, Bruijn JA, Passchier J, Pepplinkhuizen L. Motor activity and autonomic cardiac functioning in major depressive disorder. J Affect Disord 2003; 76(1-3): 23-30
32. Wakelin JS. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data. Int Clin Psychopharmacol 1986; 1(3): 221-230
33. Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Jung I, Sherwood P. Heart rate variability in patients with major depression. Psychiatry Res 1991; 37(1): 35-46
34. Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Weinberg P et al. Effect of imipramine treatment on heart rate variability measures. Neuropsychobiology 1992; 26(1-2): 27-32
35. Yeragani VK. Heart rate and blood pressure variability: implications for psychiatric research. Neuropsychobiology 1995; 32(4): 182-191